4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-15-003950
CIK 0000875622operating
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 9:53 AM ET
Size
8.4 KB
Accession
0001062993-15-003950
Insider Transaction Report
Form 4
Gitman Paul
Director
Transactions
- Sale
Common Stock, $0.001 par value
2015-07-20$53.00/sh−8,692$460,676→ 51,825 total - Exercise/Conversion
Common Stock, $0.001 par value
2015-07-20$13.60/sh+8,692$118,211→ 60,517 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-07-20−8,692→ 0 totalExercise: $13.60Exp: 2018-06-09→ Common Stock, $0.001 par value (8,692 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- [F2]All 8,692 shares sold on July 20, 2015 were executed at a price point of $53.00.
- [F3]The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 9:53 AM ET
- Size
- 8.4 KB